Table 3 Influence of socioeconomic deprivation of living area on cancer incidence in females in Normandy between 1997 and 2009

Breast

< 0.025

< 0.05

-0.016

[-0.032; 0.001]

Colon-rectum

< 0.025

< 0.05

-0.001

[-0.026; 0.026]

Corpus uteri

< 0.025

< 0.05

0.024

[-0.011; 0.059]

Lung

< 0.025

< 0.05

0.075

[0.037; 0.113]

1.08

Ovary

0.69

< 0.05

-0.031

[-0.069; 0.006]

Melanoma

0.49

< 0.05

-0.028

[-0.068; 0.012]

Non-Hodgkin lymphoma

0.79

< 0.05

-0.004

[-0.046; 0.038]

Thyroid

< 0.025

< 0.05

0.002

[-0.043; 0.047]

Central nervous system

< 0.025

< 0.05

0.024

[-0.044; 0.051]

Cervix uteri

< 0.025

< 0.05

0.094

[0.052; 0.136]

1.10

Kidney

< 0.025

< 0.05

0.021

[-0.026; 0.068]

Stomach

< 0.025

< 0.05

0.007

[-0.052; 0.067]

Pancreas

0.05

< 0.05

0.045

[-0.004; 0.091]

Unknown primary site

0.56

< 0.05

0.065

[0.015; 0.113]

1.08

Bladder

< 0.025

< 0.05

0.033

[-0.023; 0.086]

Lips-mouth-pharynx

< 0.025

< 0.05

0.103

[0.054; 0.150]

1.11

Myeloma

0.35

< 0.05

-0.038

[-0.096; 0.020]

Lymphocytic leukemia

< 0.025

< 0.05

0.041

[0.024; 0.104]

Leukemia

0.04

< 0.05

-0.036

[-0.107; 0.034]

Gall-Bladder and

0.93

< 0.05

-0.014

[-0.097; 0.068]

Extrahepatic bilary tract

Liver

< 0.025

< 0.05

0.078

[-0.002; 0.154]

Esophagus

0.40

< 0.05

0.068

[-0.017; 0.151]

Hodgkin’s lymphoma

0.33

0.11

Small intestine

0.88

0.14

Larynx

< 0.025

0.06

0.110

[-0.005; 0.217]

Mesothelioma

< 0.025

0.05

0.040

[-0.144; 0.205]